BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24348831)

  • 1. Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.
    Hu A; Dong X; Liu X; Zhang P; Zhang Y; Su N; Chen Q; Feng Y
    Oncol Lett; 2014 Jan; 7(1):115-120. PubMed ID: 24348831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on prohibition of high mobility group chromosomal protein N2 against human oral squamous cell carcinoma in vitro].
    Dong X; Liu X; Zhang Y; Zhang P; Lu L; Li X; Huang P; Feng Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):91-5. PubMed ID: 23484311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGN2 protein inhibits the growth of infected T24 cells in vitro.
    Wei D; Zhang P; Zhou M; Feng Y; Chen Q
    J Cancer Res Ther; 2014; 10(2):299-304. PubMed ID: 25022381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.
    Su L; Hu A; Luo Y; Zhou W; Zhang P; Feng Y
    Mol Cancer; 2014 Jul; 13():178. PubMed ID: 25060707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.
    Li Q; Chen J; Li X; Cui B; Fan Y; Geng N; Chen Q; Zhang P; Feng Y
    Oncol Lett; 2018 Apr; 15(4):4517-4522. PubMed ID: 29541221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
    Tian X; Zeng G; Li X; Wu Z; Wang L
    Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGN2: An Antitumor Effector Molecule of γδT Cells.
    Chen J; Fan Y; Cui B; Li X; Yu Y; Du Y; Chen Q; Feng Y; Zhang P
    J Immunother; 2018 Apr; 41(3):118-124. PubMed ID: 29401165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines.
    Liang G; Xu E; Yang C; Zhang C; Sheng X; Zhou X
    Oncol Rep; 2015 Mar; 33(3):1300-6. PubMed ID: 25530340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial mechanism of high-mobility group nucleosomal-binding domain 2 on the Gram-negative bacteria Escherichia coli.
    Li H; Shen XF; Zhou XE; Shi YE; Deng LX; Ma Y; Wang XY; Li JY; Huang N
    J Zhejiang Univ Sci B; 2017 May; 18(5):410-420. PubMed ID: 28471113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?
    Feng Y; Huang N; Wu Q; Wang B
    J Leukoc Biol; 2005 Nov; 78(5):1136-41. PubMed ID: 16204630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
    Wang AX; Li S; Ding XQ; Chen Y; Chen D
    Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation and purification of antimicrobial polypeptide HMGN2 from human lymph node and analysis of its distribution].
    Li W; Zhang P; Kong X; Li Y; Chen S; Feng Y; Wu Q; Wang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):842-6. PubMed ID: 20842856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients.
    Bin-Alee F; Arayataweegool A; Buranapraditkun S; Mahattanasakul P; Tangjaturonrasme N; Hirankarn N; Mutirangura A; Kitkumthorn N
    Oral Dis; 2021 Sep; 27(6):1394-1402. PubMed ID: 32892371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).
    Feng Y; Huang N; Wu Q; Bao L; Wang BY
    Acta Pharmacol Sin; 2005 Sep; 26(9):1087-92. PubMed ID: 16115376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
    Li X; Yang B; Han G; Li W
    J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effects of high mobility group chromosomal protein N2 on human tongue carcinoma transplanted in nude mice].
    Liu X; Dong X; Zhang Y; Zhang P; Li X; Chen S; Feng Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Feb; 32(1):5-8. PubMed ID: 24665631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Teniposide inducing apoptosis and G2/M phase arrest of Tca8113 cells].
    Li JZ; Chen WT; Li NY; Zhang P; Xu Q; Zhou XJ
    Shanghai Kou Qiang Yi Xue; 2005 Jun; 14(3):267-72. PubMed ID: 15995774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ATRA, acitretin and tazarotene on growth and apoptosis of Tca8113 cells.
    Ran L; Tan W; Tan S; Zhang R; Wang W; Zeng W
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):393-6. PubMed ID: 16196285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group nucleosomal binding domain 2 protein protects bladder epithelial cells from Klebsiella pneumoniae invasion.
    Cao Y; Wu G; Fan B; Zheng F; Gao X; Liu N; Liu X; Huang N
    Biol Pharm Bull; 2011; 34(7):1065-71. PubMed ID: 21720014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.